a combination of symptoms may include seizures intellectual disability developmental delay behavioral problems skin abnormalities lung disease and kidney disease tsc is caused by a mutation of either of two genes tsc1 and tsc2 which code for the proteins hamartin and tuberin respectively with tsc2 mutations accounting for the majority and tending to cause more severe symptoms these proteins act as tumor growth suppressors agents that regulate cell proliferation and differentiation prognosis is highly variable and depends on the symptoms but life expectancy is normal for many the prevalence of the disease is estimated to be 7 to 12 in 100 000 the disease is often abbreviated to tuberous sclerosis which refers to the hard swellings in the brains of patients first described by french neurologist d sir magloire bourneville in 1880 the physical manifestations of tsc are due to the formation of hamartia malformed tissue such as the cortical tubers hamartomas benign growths such as facial angiofibroma and subependymal nodules and very rarely cancerous hamartoblastomas the effect of these on the brain leads to neurological symptoms such as seizures intellectual disability developmental delay and behavioral problems three types of brain tumours are associated with tsc classic intracranial manifestations of